Latest Insider Transactions at Idera Pharmaceuticals, Inc. (IDRA)
This section provides a real-time view of insider transactions for Idera Pharmaceuticals, Inc. (IDRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IDERA PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IDERA PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2021
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
1,465
-3.55%
|
$4,395
$3.91 P/Share
|
|
Jan 05
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
862
-2.37%
|
$2,586
$3.9 P/Share
|
|
Jan 04
2021
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
3,515
+8.54%
|
$14,060
$4.02 P/Share
|
|
Jan 04
2021
|
James A Geraghty |
BUY
Grant, award, or other acquisition
|
Direct |
4,851
+4.43%
|
$19,404
$4.02 P/Share
|
|
Jan 04
2021
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
3,452
+8.31%
|
$13,808
$4.02 P/Share
|
|
Jan 04
2021
|
Carol Schafer |
BUY
Grant, award, or other acquisition
|
Direct |
3,620
+6.95%
|
$14,480
$4.02 P/Share
|
|
Dec 22
2020
|
Vincent Milano |
SELL
Open market or private sale
|
Direct |
37,169
-14.77%
|
$148,676
$4.32 P/Share
|
|
Dec 18
2020
|
Vincent Milano |
BUY
Grant, award, or other acquisition
|
Direct |
128,170
+33.74%
|
-
|
|
Dec 11
2020
|
Pillar Invest Corp > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
69,941
+1.26%
|
$69,941
$1.82 P/Share
|
|
Oct 01
2020
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
5,722
+14.36%
|
$11,444
$2.25 P/Share
|
|
Oct 01
2020
|
James A Geraghty |
BUY
Grant, award, or other acquisition
|
Direct |
8,666
+7.98%
|
$17,332
$2.25 P/Share
|
|
Oct 01
2020
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
6,166
+15.11%
|
$12,332
$2.25 P/Share
|
|
Oct 01
2020
|
Howard H Pien Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,583
+10.94%
|
$11,166
$2.25 P/Share
|
|
Oct 01
2020
|
Carol Schafer |
BUY
Grant, award, or other acquisition
|
Direct |
6,111
+11.99%
|
$12,222
$2.25 P/Share
|
|
Jul 01
2019
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
5,928
+0.45%
|
$11,856
$2.61 P/Share
|
|
Jun 06
2019
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
43,858
+50.0%
|
-
|
|
Jun 06
2019
|
Baker Bros. Advisors LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
238,234
-66.99%
|
-
|
|
Apr 01
2019
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
12,483
+1.78%
|
$24,966
$2.59 P/Share
|
|
Jan 02
2019
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
10,974
+1.63%
|
$32,922
$3.52 P/Share
|
|
Oct 01
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
7,020
+1.1%
|
$56,160
$8.71 P/Share
|
|
Jul 02
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
49,149
+0.99%
|
$49,149
$1.32 P/Share
|
|
Apr 02
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
40,047
+0.83%
|
$40,047
$1.62 P/Share
|
|
Mar 15
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,316,327
+37.19%
|
$0
$0.47 P/Share
|
|
Jan 02
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
27,999
+1.98%
|
$55,998
$2.21 P/Share
|
|
Oct 26
2017
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,000,000
+30.24%
|
$8,000,000
$1.5 P/Share
|
|
Oct 02
2017
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
27,135
+2.16%
|
$54,270
$2.28 P/Share
|